Keyphrases
Kinase Inhibitor
100%
Colorectal Cancer Patients
100%
NFE2L2
100%
Poor Prognosis
100%
Two-level
100%
AT9283
100%
Cancer Cells
22%
Aurora Kinase Inhibitor
22%
Colorectal Tumor
22%
Patient Prognosis
22%
Hyperactivity
22%
Vulnerability
11%
Tumor Subtype
11%
Nuclear Factor-erythroid 2 p45-related Factor 2
11%
Patient Samples
11%
In Silico
11%
Pharmacological Activation
11%
Colorectal Cancer Cells
11%
CRISPR-Cas9 Technology
11%
Drug Screen
11%
Colorectal Cancer Cell Lines
11%
Resistance to Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase Inhibitor
100%
Prothrombin
100%
Colorectal Carcinoma
100%
1 Cyclopropyl 3 [3 (5 Morpholinomethyl 1h Benzimidazol 2 Yl) 1h Pyrazol 4 Yl]urea
100%
Malignant Neoplasm
20%
Aurora Kinase Inhibitor
20%
Colorectal Tumor
20%
Neoplasm
10%
Nuclear Factor
10%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Phosphotransferase
100%
Kinase
100%
Aurora Kinase
50%
Genetics
25%
CRISPR/Cas9
25%